文献速递介入腹部技术与安全PETCTMR

18F-FDG PET生物标志物有助于在大鼠肝肿瘤模型中早期检测不可逆电穿孔的代谢反应并预测治疗结局

18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.
PubMed 文献 · Radiology · 2017-12-12

研究在大鼠肝肿瘤模型中验证18F-FDG PET生物标志物能否早期检测不可逆电穿孔(IRE)的治疗反应。治疗灶与对照灶的ΔSUVmax、ΔDmax及凋亡指数均存在显著差异(P均<.001);IRE后3天ΔSUVmax与14天ΔDmax(R=0.66,P=.01)及凋亡指数(R=0.57,P=.04)相关。结论认为18F-FDG PET影像生物标志物可用于该模型中IRE治疗反应的早期检测。

要点

  • IRE后3天ΔSUVmax与14天ΔDmax相关(R=0.66,P=.01),可用于早期预测治疗反应。
  • IRE后3天ΔSUVmax与14天凋亡指数相关(R=0.57,P=.04)。
  • 治疗灶与未治疗灶的ΔSUVmax、ΔDmax及凋亡指数差异均有统计学意义(P均<.001)。

核心结论

  • 在大鼠肝肿瘤模型中,18F-FDG PET影像生物标志物可用于IRE治疗反应的早期检测。

研究设计与样本

  • 动物实验研究,大鼠左中叶与左外叶接种McA-RH7777肝肿瘤细胞,肿瘤生长7天至最长径通常至少5 mm并经MR成像核实。

关键影像表现/征象

  • IRE后3天计算ΔSUVmax,IRE后14天以轴位T2加权成像测量ΔDmax。
  • 14天随访MR成像后处死大鼠取瘤,行苏木精-伊红、CD34及caspase-3染色,并以caspase-3染色切片计算凋亡指数。

诊断标准与关键数值

  • 治疗灶与未治疗灶的ΔSUVmax、ΔDmax及凋亡指数差异均有统计学意义(P均<.001)。
  • 治疗灶中,IRE后3天ΔSUVmax与IRE后14天ΔDmax强相关(R=0.66,P=.01)。
  • 治疗灶中,IRE后3天ΔSUVmax与IRE后14天凋亡指数相关(R=0.57,P=.04)。

临床应用与阅片要点

  • 作者结论认为18F-FDG PET影像生物标志物可用于该啮齿类模型中IRE治疗肝肿瘤治疗反应的早期检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To test the hypothesis that biomarkers of fluorine 18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET) can be used for the early detection of therapeutic response to irreversible electroporation (IRE) of liver tumor in a rodent liver tumor model. Materials and Methods The institutional animal care and use committee approved this study. Rats were inoculated with McA-RH7777 liver tumor cells in the left median and left lateral lobes. Tumors were allowed to grow for 7 days to reach a size typically at least 5 mm in longest diameter, as verified with magnetic resonance (MR) imaging. IRE electrodes were inserted, and eight 100-μsec, 2000-V pulses were applied to ablate the tumor tissue in the left median lobe. Tumor in the left lateral lobe served as a control in each animal. PET/computed tomography (CT) and MR imaging measurements were performed at baseline and 3 days after IRE for each animal. Additional MR imaging measurements were obtained 14 days after IRE. After 14-day follow-up MR imaging, rats were euthanized and tumors harvested for hematoxylin-eosin, CD34, and caspase-3 staining. Change in the maximum standardized uptake value (ΔSUVmax) was calculated 3 days after IRE. The maximum lesion diameter change (ΔDmax) was measured 14 days after IRE by using axial T2-weighted imaging. ΔSUVmax and ΔDmax were compared. The apoptosis index was calculated by using caspase-3-stained slices of apoptotic tumor cells. Pearson correlation coefficients were calculated to assess the relationship between ΔSUVmax at 3 days and ΔDmax (or apoptosis index) at 14 days after IRE treatment. Results ΔSUVmax, ΔDmax, and apoptosis index significantly differed between treated and untreated tumors (P < .001 for all). In treated tumors, there was a strong correlation between ΔSUVmax 3 days after IRE and ΔDmax 14 days after IRE (R = 0.66, P = .01) and between ΔSUVmax 3 days after IRE and apoptosis index 14 days after IRE (R = 0.57, P = .04). Conclusion 18F-FDG PET imaging biomarkers can be used for the early detection of therapeutic response to IRE treatment of liver tumors in a rodent model. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Wang X, Su Z, Lyu T, et al. 18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model. Radiology. 2017. PMID: 29232185. doi:10.1148/radiol.2017170920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。